BMS 754807 is a chemical compound used as an insulin-like growth factor 1 receptor inhibitor in pharmaceutical research and manufacturing. It is a laboratory-grade active pharmaceutical ingredient intended for supply to research institutions and drug development organizations.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1001350-96-4
7-chloro-1-[2-(ethylamino)ethyl]-5-(2-fluorophenyl)-4,5-dihydro-3H-1,4-benzodiazepin-2-one
pharmaceutical raw material
Nitrous oxide
pharmaceutical raw material
Irinotecan hydrochloride
pharmaceutical raw material
Milrinone lactate
pharmaceutical raw material
(2S)-1-[4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]pyrrolo[2,1-f][1,2,4]triazin-2-yl]-N-(6-fluoro-3-pyridinyl)-2-methylpyrrolidine-2-carboxamide
LQVXSNNAFNGRAH-QHCPKHFHSA-N
C[C@]1(CCCN1C2=NN3C=CC=C3C(=N2)NC4=NNC(=C4)C5CC5)C(=O)NC6=CN=C(C=C6)F